Novel combination demonstrated a median overall survival of nearly two years, the longest benefit ever reported in extensive stage disease in a Phase III trial Results reinforce IMFINZI as the backbone immunotherapy across stages of small cell lung cancer WILMINGTON, Del.–(BUSINESS WIRE)–Landmark results from the DeLLphi-305 Phase III trial showed IMFINZI® (durvalumab) plus Amgen’s tarlatamab-dlle …
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transaction may contain terms that could limit superior competing offers. Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you …
Investigational vaccine shows strong immune responses in infants equivalent to PREVNAR 20® on shared serotypes and for five new serotypes, potentially offering the broadest protection against invasive pneumococcal disease (IPD) for pediatric population in the U.S. NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) today announced detailed results across serotypes from a Phase 2 study (NCT06524414) for …
NEW YORK–(BUSINESS WIRE)–Rosen Law Firm, a global investor rights law firm, reminds investors about a class action on behalf of purchasers of common stock of Papa John’s International, Inc. (NASDAQ: PZZA) between August 7, 2025 and August 5, 2026. Papa Johns describes itself as a “global chain pizza company that both operates and franchises restaurants …
LOS ANGELES–(BUSINESS WIRE)–$CCC—Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in CCC Intelligent Solutions Holdings Inc. (“CCC” or “the Company”) (NASDAQ: CCC) for potential breaches of fiduciary duty on the part of its directors and management. INVESTIGATION DETAILS: The investigation focuses …
New Cellgorithm™ data presented at ISSCR symposium indicates faster, scalable cell programming and add to Syntax Bio’s compounding proprietary data Company completes pancreatic beta cell screening milestones for lead program and enters process development with continued funding from Breakthrough T1D CHICAGO–(BUSINESS WIRE)–Syntax Bio, a synthetic biology company programming next generation regenerative medicines, today presented new …
Continue reading “Syntax Bio Programs Stem Cells Toward Pancreatic Beta Cells in Four Days”
Leadership appointment and clinical milestone support the company’s continued commercial expansion and clinical evidence-generation strategy for vMap SAN DIEGO–(BUSINESS WIRE)–#Medtech–Vektor Medical, a medical technology company advancing the treatment of cardiac arrhythmias through its non-invasive, AI-based arrhythmia analysis technology, vMap®, today announced the completion of patient enrollment in its IMPRoVED-AF randomized clinical study and the appointment …
The acclaimed Oregon winery highlights decades of land preservation, a 30% lighter wine bottle, and its ongoing investment in people and community. DAYTON, Ore.–(BUSINESS WIRE)–#DomaineSerene–In recognition of Sustainability Month this October, Domaine Serene Winery is highlighting the deep-rooted stewardship decisions shaping its wines, from preserving Oregon’s landscapes to developing a lighter wine bottle and investing …
CAMBRIDGE, Mass.–(BUSINESS WIRE)–According to Forrester’s (Nasdaq: FORR) 2027 B2C marketing, customer experience, and digital predictions, rising AI costs will force B2C marketing leaders to scale back a third of AI initiatives. As AI usage grows and martech vendors increasingly adopt usage-based pricing models, every agent interaction, generated asset, and automated workflow becomes a billable event. …
Industry publication also recognizes FreeCast as its Home Streaming Solution Company of the Year, highlighting its unified media platform, enterprise PaaS technology and expanding monetization opportunities. ORLANDO, Fla.–(BUSINESS WIRE)–$CAST–FreeCast, Inc. (NASDAQ: CAST), a media technology company providing a software-based Platform-as-a-Service (PaaS) for streaming, television distribution and monetization, today announced its recognition by Media & Entertainment …